Data + Perspectives: Clinical Investigators Explore the Biology
Underlying the Role of PARP Inhibition in the Management of Common
Cancers — Faculty Presentation 2: PARP inhibitors for breast cancer
— Dr Rugo.
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.